Fortis Hiranandani Hospital, Vashi, has launched the Blood Disorder Clinic in Navi Mumbai—a center dedicated to the diagnosis, treatment, and management of blood-related conditions. The unit, helmed by Dr Subhaprakash Sanyal, director–Fortis Institute of Blood Disorders, Fortis Hospitals Mumbai, was inaugurated by Dr S Narayani, business head-Maharashtra, Fortis Hospitals and Nitin Kamaria, Facility Director, Fortis Hiranandani Hospital Vashi.
The Blood Disorder Clinic, a subset of Fortis Institute of Blood Disorders, will offer specialized care for life-threatening blood cancers such as multiple myeloma, leukemia, and other serious hematologic conditions, as well as non-cancerous blood disorders such as anemia and hematomas.
Additionally, the clinic will provide cutting-edge CAR T-cell Therapy, a treatment offering new hope for patients with certain types of blood cancers. It aims to provide comprehensive, patient-centered services for individuals in need of expert care. Dr Subhaprakash Sanyal, Director-Fortis Institute of Blood Disorders, will work closely with Dr Hamza Dalal, Consultant-Haematology and a team of specialists, to lead the Blood Disorder Clinic, providing dedicated care and support for patients and their caregivers.
“This clinic reflects our commitment to providing specialized care for those with blood-related conditions. We understand the challenges these patients face, and our goal is to provide them with the most advanced treatments, ongoing support, and a compassionate environment that promotes healing and holistic well-being. A first-of-its-kind program in Navi Mumbai is designed to be a safe space for patients to heal,” said Dr S Narayani.
“This clinic represents a rare and invaluable resource in an area of treatment that is often overlooked and under-practiced. For those battling complex blood disorders and life-threatening conditions like Leukemia or Multiple Myeloma, having access to specialized care is not just a necessity—it’s a lifeline. The Blood Disorder Clinic will offer expert treatment in a field that requires precision, dedication, and a deep understanding of these rare and challenging conditions,” said Dr Subhaprakash Sanyal, Director–Fortis Institute of Blood Disorders, Fortis Hospitals Mumbai.
